Skip to main content

Table 2 Carotid intima-media thickness and brain magnetic resonance imaging assessments

From: Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis

 

RA total (n = 41)

RA MTX (n = 12)

RA biologic (n = 29)

Control subjects (n = 60)

p Value

RA total vs control subjects

RA MTX vs control subjects

RA biologic vs control subjects

RA MTX vs RA biologic

Carotid ultrasound studies

 Right cIMT (mm)

0.72 ± 0.24

0.72 ± 0.25

0.72 ± 0.23

0.40 ± 0.28

<0.001

<0.001

<0.001

 

 Left cIMT (mm)

0.73 ± 0.23

0.69 ± 0.22

0.75 ± 0.24

0.40 ± 0.28

<0.001

<0.001

<0.001

 

 Right carotid plaques (%)

21 (51%)

8 (67%)

13 (45%)

16 (27%)

0.021

0.016

  

 Left carotid plaques (%)

18 (44%)

6 (50%)

12 (41%)

21 (35%)

    

 Right carotid plaque score

1.22 ± 1.35

1.58 ± 1.31

1.07 ± 1.36

0.60 ± 0.99

0.016

0.008

  

 Left carotid plaque score

1.00 ± 1.16

1.25 ± 1.55

0.90 ± 0.98

0.78 ± 1.12

    

Brain MRI studies

 Right vascular lesions (%)

16 (39%)

5 (42%)

11 (38%)

     

 Left vascular lesions (%)

16 (39%)

5 (42%)

11 (38%)

     

 Emollition

2 (5%)

0

2 (7%)

     

 Atrophy

8 (20%)

1 (8%)

7 (24%)

     
  1. Abbreviations: cIMT Carotid intima-media thickness, MRI Magnetic resonance imaging, MTX Methotrexate, RA Rheumatoid arthritis